Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.5416
-0.0187 (-3.34%)
At close: Oct 22, 2026, 4:00 PM EDT
0.54285
+0.0013 (0.24%)
After-hours: Oct 22, 2026, 4:04 PM EDT
Aprea Therapeutics Employees
Aprea Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Aprea Therapeutics the 40,701st largest employer in the world and 6,173rd in the United States.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$648
Profits / Employee
-$1,538,408
Market Cap
6.82M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | -2 | -22.22% |
| Dec 31, 2022 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Senti Biosciences Holdings | 39 |
| Imunon | 20 |
| FibroBiologics | 15 |
| CalciMedica | 15 |
| Soligenix | 14 |
| CNS Pharmaceuticals | 8 |
| Enveric Biosciences | 6 |
APRE News
- 2 days ago - Aprea Therapeutics Transcript: Pre-ESMO Virtual Panel Conference - Transcripts
- 6 days ago - Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology - GlobeNewsWire
- 8 days ago - Aprea Therapeutics initiated with a Buy at Ladenburg - TheFly
- 17 days ago - Aprea Therapeutics to Present at October Conferences - GlobeNewsWire
- 4 weeks ago - Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium - GlobeNewsWire
- 5 weeks ago - Aprea Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 7 weeks ago - Aprea Therapeutics provides update on existing patent portfolio - TheFly